SODIUM IODIDE I 131 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Iodide I 131, and what generic alternatives are available?
Sodium Iodide I 131 is a drug marketed by CIS, Curium, Jubilant, Cardinal Hlth 414, Intl Isotopes, and Sun Pharm Inds Inc. and is included in seven NDAs.
The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM IODIDE I 131?
- What are the global sales for SODIUM IODIDE I 131?
- What is Average Wholesale Price for SODIUM IODIDE I 131?
Summary for SODIUM IODIDE I 131
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 19 |
| Patent Applications: | 205 |
| DailyMed Link: | SODIUM IODIDE I 131 at DailyMed |
Recent Clinical Trials for SODIUM IODIDE I 131
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National University of Malaysia | PHASE2 |
| Stryker Endoscopy | Phase 4 |
| University Health Network, Toronto | Phase 4 |
Pharmacology for SODIUM IODIDE I 131
| Drug Class | Radioactive Therapeutic Agent |
| Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for SODIUM IODIDE I 131
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cis | SODIUM IODIDE I 131 | sodium iodide i-131 | CAPSULE;ORAL | 017316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Jubilant | SODIUM IODIDE I 131 | sodium iodide i-131 | CAPSULE;ORAL | 021305-004 | Nov 18, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Curium | SODIUM IODIDE I 131 | sodium iodide i-131 | CAPSULE;ORAL | 016517-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
